Please login to the form below

Not currently logged in
PMLiVE Top Pharma List


Revenue 2017


The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Herceptin was produced by Roche.

Back to the future

Back to the future Avastin ($6.6bn) and Herceptin ($6.5bn). ... Curiously, however, only five of the top 20 best-selling treatments are indicated for cancer: MabThera, Avastin, Herceptin, Glivec ($4.7b) and Revlimid ($4.3bn).

Roche drawn into Chinese probe into pharma

Roche drawn into Chinese probe into pharma company's oncology drugs, in particular Avastin (bevacizumab) for lung and colorectal cancer and Herceptin (trastuzumab) for breast cancer.

NICE rejects Roche's Kadcyla as "unaffordable"

NICE rejects Roche's Kadcyla as The drug is an antibody-drug conjugate (ADC) that is a follow-up to Roche's big-selling Herceptin (trastuzumab), and being appraised by NICE as a second-line treatment option ... The company is facing the threat of biosimilar competition to Herceptin

EMA warns on stolen Herceptin

EMA warns on stolen Herceptin Batches of the cancer drug Herceptin have been stolen and reintroduced illegally into the supply chain, according to European authorities. ... However, unlike Herceptin there has been no evidence that any of the stolen vials of Alimta or Remicade have

Herceptin could face biosimilars in UK later this year

Herceptin could face biosimilars in UK later this year European sales accounted for a little over $2.5bn of Herceptin's turnover last year, with the UK making up a fraction of that total. ... The company is also trying to shift patients from Herceptin to other HER2-targeting drugs in its portfolio, notably

[ Previous 5 results ] 19 20 21 22 23 24 25 26 27 28 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts


Add my company
Creative Medical Research

Specialising in medical device market research and participant recruitment human factors research, our approach is people-centric. We thrive on making...

Latest intelligence

Report: Customer experience, shaping digital healthcare
In this issue of ‘Perspective’ we speak with industry experts to learn about the world of digital healthcare, and how pharma is beginning to utilise these modern technologies to enhance...
Encouraging signs in biomarker R&D
The cancer immunotherapy firms ramping-up biomarker R&D...
Programmatic methodology and why you should be using it
What is it? How does it work? Why is everyone talking about it? By Richard Webb - Associate Director...